Literature DB >> 25274774

Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins.

Yoshihiro Kino1, Chika Washizu2, Masaru Kurosawa3, Yoko Oma4, Nobutaka Hattori5, Shoichi Ishiura4, Nobuyuki Nukina6.   

Abstract

In some neurological diseases caused by repeat expansions such as myotonic dystrophy, the RNA-binding protein muscleblind-like 1 (MBNL1) accumulates in intranuclear inclusions containing mutant repeat RNA. The interaction between MBNL1 and mutant RNA in the nucleus is a key event leading to loss of MBNL function, yet the details of this effect have been elusive. Here, we investigated the mechanism and significance of MBNL1 nuclear localization. We found that MBNL1 contains two classes of nuclear localization signal (NLS), a classical bipartite NLS and a novel conformational NLS. Alternative splicing of exon 7 acts as a switch between these NLS types and couples MBNL1 activity and intracellular localization. Depending on its nuclear localization, MBNL1 promoted nuclear accumulation of mutant RNA containing a CUG or CAG repeat, some of which produced proteins containing homopolymeric tracts such as polyglutamine. Furthermore, MBNL1 repressed the expression of these homopolymeric proteins including those presumably produced through repeat-associated non-ATG (RAN) translation. These results suggest that nuclear retention of expanded RNA reflects a novel role of MBNL proteins in repressing aberrant protein expression and may provide pathological and therapeutic implications for a wide range of repeat expansion diseases associated with nuclear RNA retention and/or RAN translation.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25274774     DOI: 10.1093/hmg/ddu492

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  31 in total

1.  Mechanistic determinants of MBNL activity.

Authors:  Łukasz J Sznajder; Michał Michalak; Katarzyna Taylor; Piotr Cywoniuk; Michał Kabza; Agnieszka Wojtkowiak-Szlachcic; Magdalena Matłoka; Patryk Konieczny; Krzysztof Sobczak
Journal:  Nucleic Acids Res       Date:  2016-10-12       Impact factor: 16.971

Review 2.  Myotonic dystrophy: approach to therapy.

Authors:  Charles A Thornton; Eric Wang; Ellie M Carrell
Journal:  Curr Opin Genet Dev       Date:  2017-04-01       Impact factor: 5.578

Review 3.  RNA toxicity and foci formation in microsatellite expansion diseases.

Authors:  Nan Zhang; Tetsuo Ashizawa
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

4.  Integrative transcriptomic analysis suggests new autoregulatory splicing events coupled with nonsense-mediated mRNA decay.

Authors:  Dmitri Pervouchine; Yaroslav Popov; Andy Berry; Beatrice Borsari; Adam Frankish; Roderic Guigó
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

5.  MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.

Authors:  Marianne Goodwin; Apoorva Mohan; Ranjan Batra; Kuang-Yung Lee; Konstantinos Charizanis; Francisco José Fernández Gómez; Sabiha Eddarkaoui; Nicolas Sergeant; Luc Buée; Takashi Kimura; H Brent Clark; Joline Dalton; Kenji Takamura; Sebastien M Weyn-Vanhentenryck; Chaolin Zhang; Tammy Reid; Laura P W Ranum; John W Day; Maurice S Swanson
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

6.  Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31.

Authors:  Taro Ishiguro; Nozomu Sato; Morio Ueyama; Nobuhiro Fujikake; Chantal Sellier; Akemi Kanegami; Eiichi Tokuda; Bita Zamiri; Terence Gall-Duncan; Mila Mirceta; Yoshiaki Furukawa; Takanori Yokota; Keiji Wada; J Paul Taylor; Christopher E Pearson; Nicolas Charlet-Berguerand; Hidehiro Mizusawa; Yoshitaka Nagai; Kinya Ishikawa
Journal:  Neuron       Date:  2017-03-23       Impact factor: 17.173

Review 7.  Molecular mechanisms underlying nucleotide repeat expansion disorders.

Authors:  Indranil Malik; Chase P Kelley; Eric T Wang; Peter K Todd
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-17       Impact factor: 113.915

8.  FUS/TLS acts as an aggregation-dependent modifier of polyglutamine disease model mice.

Authors:  Yoshihiro Kino; Chika Washizu; Masaru Kurosawa; Mizuki Yamada; Hiroshi Doi; Toru Takumi; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; Geoffrey G Hicks; Nobutaka Hattori; Tomomi Shimogori; Nobuyuki Nukina
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

9.  Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65.

Authors:  Xin Sun; Pan P Li; Shanshan Zhu; Rachael Cohen; Leonard O Marque; Christopher A Ross; Stefan M Pulst; Ho Yin Edwin Chan; Russell L Margolis; Dobrila D Rudnicki
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

10.  Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteins.

Authors:  Sandro Alves; Thibaut Marais; Maria-Grazia Biferi; Denis Furling; Martina Marinello; Khalid El Hachimi; Nathalie Cartier; Merle Ruberg; Giovanni Stevanin; Alexis Brice; Martine Barkats; Annie Sittler
Journal:  Mol Neurodegener       Date:  2016-07-28       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.